ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: FR-PO0002

Prognostic Prediction Model for CKD Stages by Machine Learning in Patients with ADPKD: A Nationwide Cohort Study in Japan

Session Information

Category: Artificial Intelligence, Digital Health, and Data Science

  • 300 Artificial Intelligence, Digital Health, and Data Science

Authors

  • Shimada, Yosuke, Intelligent Systems Laboratory, SECOM CO., LTD., Tokyo, Japan
  • Kataoka, Hiroshi, Department of Nephrology, Tokyo Women's Medical University, Tokyo, Japan
  • Nishio, Saori, Department of Hemodialysis and Apheresis, Hokkaido University Hospital, Hokkaido, Japan
  • Hoshino, Junichi, Department of Nephrology, Tokyo Women's Medical University, Tokyo, Japan
  • Hiromura, Keiju, Department of Nephrology and Rheumatology, Gunma University Graduate School of Medicine, Gunma, Japan
  • Isaka, Yoshitaka, Department of Nephrology, Graduate School of Medicine, The Univeristy of Osaka, Osaka, Japan
  • Muto, Satoru, Department of Urology, Juntendo University Nerima Hospital, Tokyo, Japan
Background

Autosomal dominant polycystic kidney disease (ADPKD) is a common cause of chronic kidney disease (CKD), and frequently progresses to end-stage renal disease. Accurately predicting CKD progression in ADPKD patients is essential for personalized treatment strategies. Several prognostic prediction models have been proposed, however, the utilization of machine learning (ML) in this context has not been sufficiently explored. Therefore, this study aims to develop a ML model to predict the progression of CKD stage in ADPKD patients.

Methods

This study analyzed data from 2,737 ADPKD patients enrolled in the Japanese Nationwide Cohort. Using this dataset, we developed three ML models to predict CKD stages; random forest, support vector machine, and naïve Bayes. These models were evaluated for their predictive accuracy. Feature importance analysis was performed to identify key predictive variables.

Results

Random forest exhibited the highest predictive accuracy among the three models. Feature importance analysis identified the estimated glomerular filtration rate (eGFR), serum creatinine, the CKD heat map, urinary protein, and total kidney volume as the most significant predictors of CKD stage. As a nonlinear model, random forest effectively captured the complex interactions between the variables, outperforming the linear support vector machine.

Conclusion

These findings suggest that considering complex interactions among explanatory variables may be important for predicting accurate CKD stage, as demonstrated by the superior performance of the nonlinear random forest model. These findings emphasize ML’s potential in personalized CKD management and highlight the need for individualized treatment approaches.

Comparison of accuracy and ROC-AUC among three methods

Funding

  • Commercial Support – Otsuka Pharmaceutical Co., Ltd., Chugai Pharmaceutical Co., Ltd., Kyowa Hakko Kirin Co., Ltd., and JMS Co. Ltd.

Digital Object Identifier (DOI)